Sponsor
  • ·
  • Chinese Association of
    Integrative Medicine;
    China Academy of Chinese
    Medicine Sciences
Editing
  • ·
  • Editorial Board of
    China Journal of
    Orthopaedics and Traumatology
Publishing
  • ·
  • Publishing House,
    China Journal of
    Orthopaedics and Traumatology
Overseas Distributor
  • ·
  • China International Book
    Trading Corporation
    P.O.Box 399,Beijing,China
    Code No.M587
Mail-order
  • ·
  • Publishing House,
    China Journal of
    Orthopaedics and Traumatology
    No.16A, Nanxiaojie, Dongzhimennei,
    Beijing 100700,China
    Tel:0086-10-84020925
    Fax:0086-10-84036581
    Http://www.zggszz.com
    E-mail:zggszz@sina.com
老年类风湿性关节炎治疗进展
Hits: 2331   Download times: 1269   Received:July 11, 2016    
作者Author单位UnitE-Mail
王鑫 WANG Xin 兰州大学第二医院风湿免疫科, 甘肃 兰州 730030 Department of Rheumatology, Lanzhou University Second Hospital, Lanzhou 730030, Gansu, China  
赵琴 ZHAO Qin 兰州大学第二医院风湿免疫科, 甘肃 兰州 730030 Department of Rheumatology, Lanzhou University Second Hospital, Lanzhou 730030, Gansu, China  
邓肇达 DENG Zhao-da 兰州大学第二医院风湿免疫科, 甘肃 兰州 730030 Department of Rheumatology, Lanzhou University Second Hospital, Lanzhou 730030, Gansu, China  
王晓元 WANG Xiao-yuan 兰州大学第二医院风湿免疫科, 甘肃 兰州 730030 Department of Rheumatology, Lanzhou University Second Hospital, Lanzhou 730030, Gansu, China  
张思功 ZHANG Si-gong 兰州大学第二医院风湿免疫科, 甘肃 兰州 730030 Department of Rheumatology, Lanzhou University Second Hospital, Lanzhou 730030, Gansu, China  
沈海丽 SHEN Hai-li 兰州大学第二医院风湿免疫科, 甘肃 兰州 730030 Department of Rheumatology, Lanzhou University Second Hospital, Lanzhou 730030, Gansu, China shl523194@sohu.com 
期刊信息:《中国骨伤》2017年30卷,第6期,第576-580页
DOI:10.3969/j.issn.1003-0034.2017.06.019
基金项目:国家自然科学基金(编号:81560267);兰州大学第二医院院内博士科研基金(编号:ynbskyjj2015-1-14)
老年类风湿性关节炎患者在选择NSAIDs药物时,需评估老年患者的危险因素。目前研究热点多集中于生物制剂治疗,老年患者使用生物制剂时应更多关注其感染的风险。传统中医药方案疗效确切,尤以雷公藤为突出,应开展大型关于中西医治疗老年类风湿性关节炎临床试验精确用药策略。老年患者更易合并心血管疾病、间质性肺病等共存病,治疗共存病同时也可控制类风湿本身疾病活动。老年类风湿性关节炎与其他年龄发病类风湿性关节炎一致,也需要“达标治疗”,以疾病完全缓解及降低疾病活动度为目标,但由于老年类风湿性关节炎的发病及临床特点及治疗策略与其他年龄发病类风湿性关节炎不同,因此其达标治疗理念可能也会有所不同,目前临床试验多将老年患者排除在外,导致相应循证数据缺乏。因此需开展针对老年患者的临床研究,为临床治疗方案提供依据和指导。
[关键词]:老年人  类风湿性关节炎  治疗
 
Progress on rheumatoid arthritis in elderly
Abstract:During choosing non-steroidal anti-inflammatory drugs(NSAIDs),risk factors should be evaluated in elder patients with rheumatoid arthritis. The present study focused on biological therapies,and elderly patients should be more concerned about the risk of infection when used it. Traditional Chinese medicine has advantages of obvious curative effect,especially for tripterygium wilfordii,large clinical trial on western and Chinese medical accurate drug strategies for old patients with rheumatoid arthritis. Old patients are easier to suffer from cardiac diseases and interstitial lung disease,rheumatoid arthritis could be controlled along with the treatment for coexistent disease. The incidence of rheumatoid arthritis in old patients is the same with other RA,and need to treat to target based on the aim of relieve pain and reduce activity of diseases,while the clinical charteristic and treatment target in elder patients with rheumatoid arthritis were not similar with other aged patient,so treatment standard target would vary with aging. Resent clinical studies excluded old patients,lead to lack of evidence-based medicine data. Clinical study for elder patients with rheumatoid arthritis are energetically carrying out,and could provide base and guide for clinical treatment.
KEYWORDS:Aged  Rheumatoid arthritis  Treatment
 
引用本文,请按以下格式著录参考文献:
中文格式:王鑫,赵琴,邓肇达,王晓元,张思功,沈海丽.老年类风湿性关节炎治疗进展[J].中国骨伤,2017,30(6):576~580
英文格式:WANG Xin,ZHAO Qin,DENG Zhao-da,WANG Xiao-yuan,ZHANG Si-gong,SHEN Hai-li.Progress on rheumatoid arthritis in elderly[J].zhongguo gu shang / China J Orthop Trauma ,2017,30(6):576~580
View Full Text  View/Add Comment  Download reader
Close




版权所有:Editorial Office of China Journal of Orthopaedics and Traumatology京ICP备12048066号  版权声明
地址:No.16A, Nanxiaojie, Dongzhimennei, Beijing 100700, China
电话:0086-10-84036581 传真:0086-10-84036581 Email:zggszz@sina.com